Jacobson Pharma Corp. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Jacobson Pharma Corp. Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 7.43% vs 15.79% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 43.10% vs 1.35% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,576.90",
          "val2": "1,467.80",
          "chgp": "7.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "512.60",
          "val2": "429.90",
          "chgp": "19.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "41.40",
          "val2": "78.70",
          "chgp": "-47.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-31.70",
          "val2": "-7.40",
          "chgp": "-328.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "300.80",
          "val2": "210.20",
          "chgp": "43.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "233.80%",
          "val2": "196.30%",
          "chgp": "3.75%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,576.90

1,467.80

7.43%

Operating Profit (PBDIT) excl Other Income

512.60

429.90

19.24%

Interest

41.40

78.70

-47.40%

Exceptional Items

-31.70

-7.40

-328.38%

Consolidate Net Profit

300.80

210.20

43.10%

Operating Profit Margin (Excl OI)

233.80%

196.30%

3.75%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 7.43% vs 15.79% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 43.10% vs 1.35% in Mar 2024

All Annual Results